<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00579228</url>
  </required_header>
  <id_info>
    <org_study_id>124-07</org_study_id>
    <nct_id>NCT00579228</nct_id>
  </id_info>
  <brief_title>Vascular Risk Progression in Normal and Diabetic Control Subjects.</brief_title>
  <official_title>Vascular Risk Progression in Normal and Diabetes Control Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to look at the progression of cardiovascular disease (CVD) in
      normal control individuals and in patients with controlled diabetes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiovascular disease remains the greatest cause of mortality in people with diabetes
      mellitus. This observation study will evaluate non-traditional risk factors for their
      contributions to vascular disease progression as determined by carotid intima media thickness
      and history of vascular disease events over 1 year. This study requires annual checks of
      blood, urine, history, and carotid ultrasound for carotid intimal medical thickness.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Actual">March 29, 2018</completion_date>
  <primary_completion_date type="Actual">March 29, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To describe carotid intima media measurement change over 2 year period in normal individuals compared to individuals with well controlled diabetes</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">90</enrollment>
  <condition>Diabetes</condition>
  <condition>Inflammation</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Normal controls both men and women</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Individuals with type 2 Diabetes with good control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Individuals with type 1 diabetes with good control</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Any patient with diabetes or healthy individuals
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19 years old or more and willing to return for annual testing for 2 years.

          -  Those with Diabetes need to have the condition for at least 5 years.

          -  Normal controls need to have no diabetes, kidney disease, or chronic disease.

        Exclusion Criteria:

          -  Estimated GFR &lt;60 (mL/min/1.73m2)

          -  Any condition that would change weight dramatically in the near future such as
             malabsorption, pregnancy, malignancy

          -  For Normal: BMI&gt;30, BP &gt; 140/90 , LDL &gt; 130.

          -  For Diabetes: BP&gt; 135/85, A1C&gt; 8%. LDL &gt; 100.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer Larsen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UNMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198-3020</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 19, 2007</study_first_submitted>
  <study_first_submitted_qc>December 21, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2007</study_first_posted>
  <last_update_submitted>March 29, 2018</last_update_submitted>
  <last_update_submitted_qc>March 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Nebraska</investigator_affiliation>
    <investigator_full_name>Jennifer Larsen, MD</investigator_full_name>
    <investigator_title>Vice Chancelor of Research</investigator_title>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Vascular risk</keyword>
  <keyword>Inflammation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

